InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
0.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by ANIDO ARMANDO, Chief Executive Officer. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 12 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €20k. Activity tracked since 26 January 2022. The latest transaction was filed on 20 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
2,875 sharesCommon StockSEC:0001219866-26-000002:0
23,000 shares0Common StockSEC:0000950170-24-076203:0
566,722 sharesCommon StockSEC:0001140361-23-047723:0
64,747 sharesCommon StockSEC:0001062993-23-018018:0
10,000 shares0Common StockSEC:0000950170-23-029630:0
45,406 sharesCommon StockSEC:0000899243-23-004442:0
42,437 sharesCommon StockSEC:0000899243-23-003732:0
35,453 shares@ US$0.5978100.0% of flowCommon StockSEC:0001062993-23-001384:0
43,164 sharesCommon StockSEC:0001062993-22-016555:0
10,000 shares0Common StockSEC:0001209191-22-038652:0
120,000 shares0Common StockSEC:0001062993-22-001787:0
120,000 shares0Common StockSEC:0001062993-22-001787
12 of 12 declarations
About ANIDO ARMANDO
Armando Anido is the Chairman and CEO of Zynerba Pharmaceuticals, Inc. and SCYNEXIS Inc. He is responsible for the strategic direction of both companies, overseeing their operations and ensuring growth.
